We are live on ! Find out more
ELGX

Endologix Inc
ELGX

Delisted

ELGX was delisted on the 15th of July, 2020.

99 hedge funds and large institutions have $56M invested in Endologix Inc in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 25

5% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 21

1% less funds holding

Funds holding: 10099 (-1)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

63% less capital invested

Capital invested by funds: $152M → $56M (-$95.9M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
99
Holders Change
-1
Holders Change %
-1%
% of All Funds
2.21%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
20
Increased
31
Reduced
25
Closed
21
Calls
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$124K
Name Holding Trade Value Shares
Change
Change in
Stake
AllianceBernstein
51
AllianceBernstein
Tennessee
$72K -$14K -1,260 -11%
RJFSA
52
Raymond James Financial Services Advisors
Florida
$71K +$89.2K +8,010 +408%
Jane Street
53
Jane Street
New York
$67K +$36.8K +3,304 +55%
USAA
54
United Services Automobile Association
Texas
$63K
California Public Employees Retirement System
55
California Public Employees Retirement System
California
$60K
Assenagon Asset Management
56
Assenagon Asset Management
Luxembourg
$55K +$85.6K +7,690 New
UBS Group
57
UBS Group
Switzerland
$52K +$67.3K +6,040 +509%
Invesco
58
Invesco
Georgia
$51K +$13.4K +1,207 +21%
AIG
59
American International Group
New York
$48K +$13.6K +1,224 +22%
QSS
60
Quantitative Systematic Strategies
Florida
$46K +$16.7K +1,503 +30%
Macquarie Group
61
Macquarie Group
Australia
$46K +$72.3K +6,489 New
Susquehanna International Group
62
Susquehanna International Group
Pennsylvania
$45K +$68.8K +6,176 New
Tudor Investment Corp
63
Tudor Investment Corp
Connecticut
$43K
State Board of Administration of Florida Retirement System
64
State Board of Administration of Florida Retirement System
Florida
$40K
Citigroup
65
Citigroup
New York
$37K +$42.2K +3,788 +279%
VFA
66
Valeo Financial Advisors
Indiana
$32K
PCM
67
Perkins Capital Management
Minnesota
$29K +$44.5K +4,000 New
VOYA Investment Management
68
VOYA Investment Management
Georgia
$25K
ZCM
69
Zebra Capital Management
Connecticut
$23K -$5.57K -500 -14%
LTFS
70
Ladenburg Thalmann Financial Services
Florida
$21K
Principal Financial Group
71
Principal Financial Group
Iowa
$21K +$2.33K +209 +7%
Prudential Financial
72
Prudential Financial
New Jersey
$20K +$31.2K +2,798 New
Public Employees Retirement Association of Colorado
73
Public Employees Retirement Association of Colorado
Colorado
$16K
TRCT
74
Tower Research Capital (TRC)
New York
$14K +$22K +1,977 New
CS
75
Credit Suisse
Switzerland
$13K -$14.4K -1,292 -41%

ELGX Hedge Fund Activity: Q4 2018 in Review

99 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Endologix Inc (ELGX) for Q4 2018, worth a combined $56M — down 63% from $152M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ELGX and 20 opened new positions — a net loss of 1 holder — while 25 trimmed existing stakes and 31 added.

The largest buyer was JP Morgan Chase, adding an estimated $931K. The largest seller was PFM Health Sciences, exiting entirely with an estimated $14.2M sold.

  • 99 institutional investors held Endologix Inc (ELGX) as of Q4 2018, down from 100 in Q3 2018.
  • Funds reported $56M of Endologix Inc stock for Q4 2018, down 63% quarter-over-quarter.
  • 20 funds opened new Endologix Inc positions in Q4 2018 and 21 closed out, a net change of -1 holder.
  • The largest Endologix Inc buyer in Q4 2018 was JP Morgan Chase, an estimated $931K added.
  • The largest Endologix Inc seller in Q4 2018 was PFM Health Sciences, an estimated $14.2M sold.

Based on aggregated 13F filings for Q4 2018.